Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Insight into Pediatric Radiotherapy Treatment at Hadassah Provided to ALYN Colleagues

ALYN staff

To gain a greater understanding of the radiation therapy and support that pediatric cancer patients receive at the Hadassah Medical Organization, psychologists, social workers, and rehabilitation nurses from ALYN Woldenberg Family Hospital, Israel's only pediatric and adolescent rehabilitation facility, visited Hadassah for an in-depth briefing and tour.

ALYN's professional staff observed Hadassah's Radiotherapy Unit, including its simulation and radiation rooms and state-of-the art radiotherapy equipment. They met with the Unit's health care team and heard presentations from Dr. Marc Wygoda, the Unit's Director, who provided them with a general overview of the radiotherapy process, and Sarit Kaduri, Head Nurse of the Radiology Unit, who explained the type of guidance and support Hadassah gives its pediatric patients and their families.

ALYN, located in Jerusalem, cares for children with a wide range of congenital and acquired conditions, including cerebral palsy, neuromuscular diseases, spinal cord injuries, brain injuries, and burns. Many of the children are Hadassah patients.

Our young patients are treated in the child-friendly Charlotte R. Bloomberg Mother & Child Center at HMO in Ein Kerem and at Hadassah Hospital on Mount Scopus. The newly expanded Pediatric Intensive Care Unit (PICU) at Ein Kerem treats critically ill patients, newborn to age 16, who are recovering from operations for head traumas, congenital heart defects, strokes and brain tumors.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

Date: 3/26/2014


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America